A critical analysis of some of the functions of the World Anti-Doping Agency (WADA) and its affiliates was performed. The manner in which the banned substance list was formed; the attribution of performance-enhancement; and the conduct of urine sample collection, transportation, analysis and reporting were found to be deficient. The secretive nature of WADA has not fostered conformity with scientific procedures and attributes, particularly the independent objective verification of principles and statement content These authors believe it is inevitable that if WADA continues its current practices, professional athletes will be driven out of the Olympic Games The actions and scope of WADA are causes for grave concern.
KalinskiM.I.DunbarC.C.SzygulaZ., Research on Anabolic Steroids in the Former Soviet Union. Medicine and Science in Sports and Exercise, 2001, 33(5), Supplement abstract 1901.
2.
RushallB.S., A Brief History of Drugs in Swimming, Australian Swimming and Fitness, 1998, March-April, 40–44.
3.
RushallB.S., The Use of Performance Enhancing Drugs in Sport, Issues in Society, 1999, 106, 21–24.
4.
British Pharmacopoeia Commission, The British Pharmacopoeia 2004, August, 2004, ISBN: 0113225954.
World Anti-Doping Agency, The 2005 Prohibited List, World Anti-Doping Agency, Montreal, Canada, 2004.
9.
AyotteC.LevesqueJ. F.ClerouxM.LajeunesseA.GoudreaultD.FakirianA., Sport Nutritional Supplements: Quality and Doping Controls, Canadian Journal of Applied Physiology, 2001, 26, Supplement S120–129.
10.
ReynoldsJ.E. (Ed.), Martindale: The Complete Drug Reference33rd edn., Pharmaceutical Press, Lambeth, London, 2002.
11.
BjorkhemE.EkH., Detection and Quantitation of 19-norandrosterone in Urine by Isotope Dilution-mass Spectrometry, Journal of Steroid Biochemistry and Molecular Biology, 1982, 17, 447–451.
12.
KicmanA.T.BrooksR.V., A Radioimmunoassay for the Metabolites of the Anabolic Steroid Nandrolone, Journal of Pharmacology and Biomedical Analysis, 1988, 6, 473–483.
13.
SeguraJ., Letter of Information to the Heads of IOC Accredited Laboratories, World Anti-Doping Agency, Montreal, Canada, August 22, 1996.
14.
BotreF., Drugs of Abuse and Abuse of Drugs in Sportsmen: The Role of In Vitro Models to Study Effects and Mechanisms, Toxicology In Vitro, 2003, 17(5–6), 509–513.
FriedlK.DettoriJ.HannanC., Comparison of the Effects of High Dose Testosterone and 19-nortestosterone to a Replacement Dose of Testosterone on Strength and Body Composition in Normal Men, Journal of Steroid Biochemistry and Molecular Biology, 1991, 40, 607–612.
22.
HartgensF.KuipersH., Effects of Androgenic-Anabolic Steroids in Athletes, Sports Medicine, 2004, 34, 513–554.
23.
PengS.H.SeguraJ.FarreM.GonzalezJ Cde la TorreX., Plasma and Urinary Markers of Oral Testosterone Undecanoate Misuse, Steroids, 2002, 67(1), 39–50.
24.
BowersR.W.ReardonJ.P., Effects of Methandostenolone (Dianabol) on Strength Development and Aerobic Capacity, Medicine and Science in Sports, 1972, 4, 54.
25.
FaheyT.D.BrownC.H., The Effects of an Anabolic Steroid on the Strength, Body Composition, and Endurance of College Males When Accompanied by a Weight Training Program, Medicine and Science in Sports, 1973, 5, 272–276.
26.
JohnsonL.C.FisherG.SilvesterL.J.HoffeinsC.C., Anabolic Steroids: Effects on Strength, Body Weight, Oxygen Uptake and Spermatogenesis Upon Mature Males, Medicine and Science in Sports, 1972, 4, 43–45.
27.
JohnsonL.C.RoundyE.S.AllsenP.E.FisherA.G.SilvesterJ., Effect of Anabolic Steroid Treatment on Endurance. Medicine and Science in Sports, 1975, 7, 287–289.
28.
LoughtonS.J.RuhlingR.O., Human Strength and Endurance Response to Anabolic Steroid and Training, Journal of Sports Medicine and Physical Fitness, 1977, 17, 285–296.
29.
WadlerG.I.HainlineB., Drugs and the Athlete, F. A. Davis, Philadelphia, PA, 1989.
30.
Doyle-BakerP.K.BensonB.W.MeeuwisseW.H., The Ergogenic Effects of Anabolic Steroids: A Critical Appraisal of the Literature, Medicine and Science in Sports and Exercise, 1998, 30(5), Supplement abstract 1581.
31.
BardinC.W., The Anabolic Action of Testosterone [Editorial], New England Journal of Medicine, 1996, 335, 52–53.
32.
CowanD.A.KicmanA. T., Doping in Sport: Misuse, Analytical Tests, and Legal Aspects, Clinical Chemistry, 1997, 43, 1110–1113.
33.
SpenceJ., Effects of Anabolic-androgenic Steroids on Muscular Strength: A Meta-analysis, Medicine and Science in Sports and Exercise, 1999, 31(5), Supplement abstract 2071.
34.
LambD.R., Anabolic Steroids in Athletics: How Well Do They Work and How Dangerous Are They?American Journal of Sports Medicine, 1984, 12(1), 31–38.
35.
KraemerW.J.RatamessN.A., Hormonal Responses and Adaptations to Resistance Exercise and Training, Sports Medicine, 2005, 35, 339–361.
36.
RushallB.S.PykeF.S., Training for Sports and Fitness, Macmillan of Australia, Melbourne, Australia, 1991.
37.
CaterisanoA.BrownC.W.ThurmondL.P.PerkinsD.R.LinnK.B.ShortridgeE.A., The Relationship Between Lower Body Strength and Power in Resistance Trained Athletes, Medicine and Science in Sports and Exercise, 1999, 31(5), Supplement abstract 225.
38.
HarneyR.G.PurcellM.Martinez-ArizalaG.ReedE.SerfassR., Relationship Between Anthropometric Measurements, Traditional Modes of Testing and Training, and Blocking Performance in Collegiate Football Linemen, Medicine and Science in Sports and Exercise, 2001, 33(5), Supplement abstract 1387.
39.
HarrisG.R.StoneM.H.O'BryantH.S.ProulxC.M.JohnsonR.L., Short-term Performance Effects of High Power, High Force, or Combined Weight-training Methods, Journal of Strength and Conditioning Research, 2000, 14, 14–20.
40.
LeggD.BurnhamR., In-season Shoulder Abduction Strength Changes in Football Players, Journal of Strength and Conditioning Research, 1999, 13, 381–383.
41.
MillerT.A.WhiteE.D.KinleyK.A.ClarkM.J.CongletonJ.J., Changes in Performance Following Long-term Resistance Training in Division 1A Collegiate Football Players, Medicine and Science in Sports and Exercise, 1999, 31(5), Supplement abstract 1467.
DeathA.K.McGrathK.C.KazlauskasR.HandelsmanD.J., Tetrahydrogestrinone is a Potent Androgen and Progestin, The Journal of Clinical Endocrinology and Metabolism, 2004, 89, 2498–2500.
MaughanR.J.KingD.S.LeaT., Dietary Supplements, Journal of Sports Sciences, 2004, 22(1), 95–113.
46.
JuhnM., Popular Sports Supplements and Ergogenic Aids, Sports Medicine, 2003, 33(12), 921–939.
47.
WeatherbyR.P.GiorgiA.KazlauskasR., Retention of Performance Gains Following Testosterone Enanthate Administration, Sixth IOC World Congress on Sport Sciences, abstract, p. 90, May, 2002.
48.
BhasinS.StorerT.W.BermanN.CallegariC.ClevengerG.PhillipsJ.BunnellT.J.TrickerR.ShirziA.CasaburiR., The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men, New England Journal of Medicine, 1996, 335, 1–7.
HeidH., Report of B-sample Testing in the Laboratory of Prof. W. Schänzer, Institute of Biochemistry, Germany, Sport University, Cologne. Monday, September 29, 2003 Until Wednesday, October 1, 2003, Unpublished report, German Cancer Research Center, Heidelberg, Germany, no date,.
DavisS.Analysis of Data Obtained from the DCC in December 2003, Unpublished document, Mass Spec Solutions, Manchester, England, February, 2005.
60.
ChesterN.ReillyT.MottramD.R., Over-the-counter Drug Use Amongst Athletes and Non-athletes, Journal of Sports Medicine and Physical Fitness, 2003, 43(1), 111–118.
BarerM.R.BogosianG., Letter to the Editor: The Viable but Nonculturable Concept, Bacteria in Urine Samples, and Occam's Razor, Journal of Clinical Microbiology, 2004, 42, 5434–5435.
BowersL. D., Doping in Sport Symposium Proceedings: Analytical advances in detection of performance-enhancing compounds, Clinical Chemistry, 1997, 43, 1299–1304.
